Voyager Therapeutics to Present at Investor Conferences in November Mon, 13 Nov 2017 17:30:00 +0000 CAMBRIDGE, Mass., Nov. 13, 2017-- Voyager Therapeutics, Inc., a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced management presentations ...
Voyager Therapeutics to Host R&D Day on November 16, 2017 Sun, 12 Nov 2017 23:00:00 +0000 CAMBRIDGE, Mass., Nov. 12, 2017-- Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, announced today it will ...
Voyager Therapeutics Announces Closing of Public Offering of Common Stock Fri, 10 Nov 2017 21:05:00 +0000 CAMBRIDGE, Mass., Nov. 10, 2017-- Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the ...
ETFs with exposure to Voyager Therapeutics, Inc. : November 8, 2017 Wed, 08 Nov 2017 23:41:29 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Voyager Therapeutics, Inc. Here are 5 ETFs with the largest exposure to VYGR-US. Comparing the performance and risk of Voyager Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
Voyager Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : VYGR-US : November 8, 2017 Wed, 08 Nov 2017 15:51:34 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Voyager Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
(Read more...)
Voyager Therapeutics Gears Up for Secondary Offering Wed, 08 Nov 2017 13:45:43 +0000 Voyager Therapeutics has seen a decent year for its shares and it seems now is the best time to cash in with a secondary offering.
Voyager Therapeutics Announces Pricing of Public Offering of Common Stock Wed, 08 Nov 2017 03:55:14 +0000 CAMBRIDGE, Mass., Nov. 07, 2017-- Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the ...
Voyager Therapeutics, Inc. :VYGR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Tue, 07 Nov 2017 13:04:21 +0000 Categories: Yahoo FinanceGet free summary analysis Voyager Therapeutics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Voyager Therapeutics, Inc. – PDL BioPharma, Inc. (PDLI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 1.15 million, Net Earnings of USD -23.35 ... Read more
(Read more...)
Voyager Therapeutics Announces Proposed Offering of Common Stock Mon, 06 Nov 2017 21:14:48 +0000 CAMBRIDGE, Mass., Nov. 06, 2017-- Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced that ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.